Generic Plavix (clopidogrel) may not be here to stay

October 2006

Generic Plavix (clopidogrel) may not be here to stay.

Apotex is challenging a patent that's not due to expire until 2011. They think they have a good case, so they launched a generic BEFORE the case was resolved.

A few days later, Bristol-Myers and Sanofi got an injunction to stop sales of the generic until a final ruling is made.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote